http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18968854

Outgoing Links

Predicate Object
contentType Journal Article
issn 2352-3409
pageRange 106858-
publicationName Data in Brief
startingPage 106858
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_92a8c7860b9170e4a626b2eb0c55b6a1
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c60d28e809da60938f73e90b84e34bed
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_96399cf467d751009df55ca07098ae89
bibliographicCitation Roy T, Boateng ST, Banang-Mbeumi S, Singh PK, Basnet P, Chamcheu RN, Ladu F, Chauvin I, Spiegelman VS, Hill RA, Kousoulas KG, Nagalo BM, Walker AL, Fotie J, Murru S, Sechi M, Chamcheu JC. Identification of new fisetin analogs as kinase inhibitors: Data on synthesis and anti-skin cancer activities evaluation. Data in Brief. 2021 Apr;35():106858. doi: 10.1016/j.dib.2021.106858.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d803751f66ef3f409c58c67cdcbecc4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_90e47b6d42d4169d8e7e2df33ef83bfc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07bffed7b038d0be248b479068dbd015
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3276d563246a37c5060ef109fd23b438
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3101-7705
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4185dbc015f6d2e19f818b1e3836603
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b0abd18227d0b81780bbb80ebb1b149
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f06b27df98de750d60ba46fb96bc71df
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e4b54d5ba31f7648ceb2dafab91a6fe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e881c851d936a48a6e5efa6e82a0981c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c521e52d8730e9a005063b7dae9593a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2809-2536
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db4c64b07bff7a7a8c86f38e87fe5c30
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4950f99cdf2a33a2cfce6e2f2234793
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48e670421a67a5afe96abf2a6961f6cf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7fa0b2cc985bb5e3e50e928e4af156d7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c35020d94d7d9d60c4bf7ce879ccb0e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e059b9f2d36017fee163f544431ac856
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7654cc9d4a815403c068cf0a2b97e2c
date 202104
identifier https://pubmed.ncbi.nlm.nih.gov/33665254
https://doi.org/10.1016/j.dib.2021.106858
https://pubmed.ncbi.nlm.nih.gov/PMC7907707
isPartOf https://portal.issn.org/resource/ISSN/2352-3409
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43807
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Identification of new fisetin analogs as kinase inhibitors: Data on synthesis and anti-skin cancer activities evaluation
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11349
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ffa044f5d18974a3264c23a5e1e06217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281614
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f6e823973728aec8c3075d39388b14dd
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9245
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049

Total number of triples: 49.